Publication | Open Access

A phase I–II study of gemcitabine and docetaxel in advanced pancreatic cancer: A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Pancreatic CancerGastrointestinal OncologyMedicineGastroenterologyPathologyItalian GroupDigestive Tract CancerPhase I–ii StudyOncologyRadiation OncologyCancer ResearchDigestive System Diseases